{"nct_id":"NCT02404350","title":"Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis","status":"COMPLETED","status_verified_date":"2020-04","start_date":"2015-08-31","start_date_type":"ACTUAL","primary_completion_date":"2017-08-16","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}